get a key
steadybase-$ company CTKB
account_id none on file
legal_name Cytek Biosciences, Inc.
ticker CTKB
cik 1831915
domain cytekbio.com
entry_point_account_id none on file
name Cytek Biosciences Inc.
exchange Nasdaq
sector Industrials
calls 5 filings 0 executives 5 family 0
why_now
GAAP gross profit margin was 53% versus 59% in the prior year quarter. This was due to both a lower service gross margin resulting from an increase in headcount and travel costs and a lower product gross margin as a result of higher materials and tariff costs and higher manufacturing overhead due to the duplicate costs from transitioning a production facility overseas.

Feb 26, 2026 / receipt

calls
GAAP gross profit margin was 53% versus 59% in the prior year quarter. This was due to both a lower service gross margin resulting from an increase in headcount and travel costs and a lower product gross margin as a result of higher materials and tariff costs and higher manufacturing overhead due to the duplicate costs from transitioning a production facility overseas.

Feb 26, 2026 / receipt, needs a key / Bill McComb, CFO | earnings call 2026-02-26 | transcript 639c05e0-e15e-477a-9994-0bdac780c643 | chars 13565-13936 | segment 13

Gap gross profit margin was 53% versus 56% in the prior year quarter. This was due to both a lower service gross margin resulting from an increase in headcount and travel costs and a lower product gross margin as a result of lower product revenues higher materials and tariff costs, and higher overhead.

Nov 5, 2025 / receipt, needs a key / Bill McComb, CFO | earnings call 2025-11-05 | transcript 11a0f2e7-ca8f-4db0-90a6-a5565dfd348a | chars 14143-14446 | segment 14

Once again, I would like to invite investors and analysts to attend the industry and academic conferences, meetings, and seminars where we will be exhibiting Scitex products. There are 43 of these events planned throughout the remainder of 2024 in the US and around the world. While these are primarily geared to the scientific community, they may offer an opportunity to interact with users of our technologies to learn why Scitex instruments are so highly valued by our customers. There is a cost to attend most events, and we have a limited number of spaces to accommodate members of the financial community. So if you are interested in attending, please contact me.

Aug 6, 2024 / receipt, needs a key / Paul Goodson, other | earnings call 2024-08-06 | transcript 4c7fb82b-6715-442a-80c9-0a7801b77abd | chars 2298-2967 | segment 2

Before Wenbin speaks, I would like to mention that SciTech will be participating in a variety of industry and academic conferences, meetings, and seminars throughout 2024. While these are primarily geared to the scientific community, they may offer an opportunity to interact with users of our technologies to learn why Scitex instruments are so highly valued by our customers. There is a cost to attend most events, and we have a limited number of spaces to accommodate members of the financial community. So if you are interested in attending, please contact me.

May 8, 2024 / receipt, needs a key / Paul Goodson, other | earnings call 2024-05-08 | transcript 7a007e60-d8cd-42e8-973a-fcde50f749d8 | chars 2385-2949 | segment 2

Finally, I would like to mention that SciTech will be participating in a variety of industry and academic conferences throughout 2024. While these are primarily geared to the scientific community, they may offer an opportunity to interact with users of our technologies to learn why SciTech's instruments are so highly valued by our customers. There is a cost to attend most events, and we have a limited number of spaces to accommodate members of the financial community. So if you are interested in attending, please contact me.

Feb 28, 2024 / receipt, needs a key / Wenbin Zhang, CEO | earnings call 2024-02-28 | transcript 974327ba-6c29-4044-bad7-b1064617ea17 | chars 2472-3002 | segment 2

filingsnone on file
executives
Bill McComb CFO - receipt
Chris Williams Vice President - receipt
Patrick Jean-Meneau CFO - receipt
Paul Goodson Head of Investor Relations - receipt
Wenbin Zhang CEO - receipt
familynone on file
upcoming
2026-11-04 earnings call scheduled ir
changes
2024-03-19 Chief Financial Officer, departed sec_8k
2022-11-01 Vice President, appointed sec_8k
mcp_package_hint
steadybase-$